Results 191 to 200 of about 37,330 (229)

In Vitro Activity of Novel β-Lactam/β-Lactamase Inhibitors Against Carbapenem-Resistant <i>Pseudomonas aeruginosa</i> and <i>Enterobacterales</i> in Korea. [PDF]

Antibiotics (Basel)
Moon S, Yi J, Ko MK, Sim YK, Kim KH.
europepmc   +1 more source

Perspectives on Metallo-β-Lactamase Inhibitors: Challenges and Implications of Metallo-β-Lactamase Variants. [PDF]

Iran J Public Health
Lee JH, Kim DW, Lee SH.
europepmc   +1 more source

What are the optimal pharmacokinetic/pharmacodynamic targets for β-lactamase inhibitors? A systematic review. [PDF]

J Antimicrob Chemother
Assefa GM, Roberts JA, Mohammed SA, Sime FB.   +3 more
europepmc   +1 more source

Antimicrobial activity of cephamycins and β-lactam/β-lactamase inhibitors against ESBL-producing Escherichia coli and Klebsiella pneumoniae under standard and high bacterial inocula. [PDF]

Sci Rep
Wi YM, Choi JY, Lee DE, Jun SH, Kwon KT, Ko KS.   +5 more
europepmc   +1 more source

Novel Siderophore Cephalosporin and Combinations of Cephalosporins with β-Lactamase Inhibitors as an Advancement in Treatment of Ventilator-Associated Pneumonia. [PDF]

Antibiotics (Basel)
Viscardi S, Topola E, Sobieraj J, Duda-Madej A.   +3 more
europepmc   +1 more source

Impact of porin deficiency on the synergistic potential of colistin in combination with β-lactam/β-lactamase inhibitors against ESBL- and carbapenemase-producing <i>Klebsiella pneumoniae</i>. [PDF]

Antimicrob Agents Chemother
Allander L, Vickberg K, Fermér E, Söderhäll T, Sandegren L, Lagerbäck P, Tängdén T.   +6 more
europepmc   +1 more source

Rates of resistance and heteroresistance to newer β-lactam/β-lactamase inhibitors for carbapenem-resistant Enterobacterales. [PDF]

JAC Antimicrob Resist
Lin CK, Page A, Lohsen S, Haider AA, Waggoner J, Smith G, Babiker A, Jacob JT, Howard-Anderson J, Satola SW.   +9 more
europepmc   +1 more source

Elucidation of critical chemical moieties of metallo-β-lactamase inhibitors and prioritisation of target metallo-β-lactamases. [PDF]

J Enzyme Inhib Med Chem
Lee JH, Kim SG, Jang KM, Shin K, Jin H, Kim DW, Jeong BC, Lee SH.   +7 more
europepmc   +1 more source

In-vitro activity of newly-developed β-lactamase inhibitors avibactam, relebactam and vaborbactam in combination with anti-pseudomonal β-lactam antibiotics against AmpC-overproducing clinical Pseudomonas aeruginosa isolates. [PDF]

Eur J Clin Microbiol Infect Dis
Le Terrier C, Raro OHF, Saad AM, Nordmann P, Poirel L.   +4 more
europepmc   +1 more source

Relative inhibitory activities of newly developed diazabicyclooctanes, boronic acid derivatives, and penicillin-based sulfone β-lactamase inhibitors against broad-spectrum AmpC β-lactamases. [PDF]

Antimicrob Agents Chemother
Le Terrier C, Mlynarcik P, Sadek M, Nordmann P, Poirel L.   +4 more
europepmc   +1 more source